Filing Details

Accession Number:
0001437749-17-016405
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-27 16:54:52
Reporting Period:
2017-09-25
Accepted Time:
2017-09-27 16:54:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1427925 Acelrx Pharmaceuticals Inc ACRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1511368 G Lawrence Hamel C/O Acelrx Pharmaceuticals, Inc.
351 Galveston Drive
Redwood City CA 94063
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-09-25 13,827 $0.00 68,504 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. 52,125 of the Shares are held in the Hamel Revocable Living Trust
  2. The Shares were sold in a range from $3.50-$4.50
  3. Non-reportable acquisition of 1,977 shares of Common Stock through the Company's Employee Stock Purchase Plan